Key facts
- Qventus’s last known valuation is $400.0M.
- It has raised $199.6M across 1 recorded rounds; the latest was Later Stage VC (Series D) ($105.0M) in Dec 2024.
- Notable investors include Y Combinator, Bessemer Venture Partners, StartX (US), FundersClub, Mayfield Fund — 20 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Qventus
Funding rounds
1 roundsAbout Qventus
Developer of a hospital management software designed for hospital teams to make operational decisions in real-time. The company's software helps to address operational challenges across the hospital, including emergency departments, preoperative areas, patient safety, inpatient, outpatient and pharmacy, enabling clients to turn data into action, reduce manual work, grow revenue and make real-time operational decisions.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2012
- Employees
- 196
- Website
- qventus.com/
- Ownership
- Privately Held (backing)
Qventus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qventus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qventus in its N-PORT filings yet. We sweep new filings monthly.